Delfini Lisa 4
4 · Trevi Therapeutics, Inc. · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Delfini Lisa
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-07$0.51/sh+1,000$511→ 59,660 total - Exercise/Conversion
Common Stock
2025-01-08$0.51/sh+5,000$2,555→ 64,660 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-07−1,000→ 47,125 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2025-01-08−5,000→ 42,125 totalExercise: $0.51Exp: 2032-02-10→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]Includes 5,381 shares purchased through the Issuer's employee stock purchase plan.
- [F2]This option was granted on February 11, 2022. The 110,000 shares of common stock underlying the option vested as to 25% of the shares on February 11, 2023 and vest as to the remaining 75% of the shares in equal monthly installments thereafter through February 11, 2026.